| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,470 |
2,769 |
$86K |
| 99091 |
|
685 |
642 |
$84K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,612 |
1,344 |
$56K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
66 |
52 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
261 |
207 |
$4K |
| 82947 |
|
1,033 |
835 |
$2K |
| 95923 |
|
49 |
32 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
155 |
122 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
31 |
27 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
29 |
27 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
140 |
124 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
52 |
37 |
$752.96 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
12 |
$405.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
30 |
29 |
$304.06 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
56 |
38 |
$250.18 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
24 |
16 |
$112.42 |
| 90461 |
|
21 |
14 |
$48.38 |
| 82962 |
|
228 |
185 |
$2.33 |
| 90658 |
|
22 |
12 |
$0.03 |
| 36415 |
Collection of venous blood by venipuncture |
207 |
161 |
$0.00 |
| 99443 |
|
14 |
12 |
$0.00 |
| 99173 |
|
16 |
16 |
$0.00 |